50% off all subscriptions! ... left. Order NowOrder Now

Anthera Pharmaceuticals Stock Forecast NASDAQ:ANTH

$0.0001 (0%)

Volume: 100

Closed: Nov 26, 2021

Hollow Logo Score: -5.375

Anthera Pharmaceuticals Stock Forecast

$0.0001 (0%)

Volume: 100

Closed: Nov 26, 2021

Score Hollow Logo -5.375
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 20 - 75 ] RSI14 is 67 and the stock is currently not being overbought or oversold

Red day on Friday for Anthera Pharmaceuticals stock after losing 0%
(Updated on Nov 26, 2021)

Sell candidate since 2021-11-17

No changes to the price of Anthera Pharmaceuticals stock on the last trading day (Friday, 26th Nov 2021). During the day the stock fluctuated 0% from a day low at $0.0001 to a day high of $0.0001. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $-0.0052, a level that may pose a second chance to hit a runner. Due to the high volatility and the trend direction we are not able to give forecast range for this stock. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Anthera Pharmaceuticals stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0001 and $0.0004. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, November 09, 2021, and so far it has fallen -50.00%. Further fall is indicated until a new bottom pivot has been found. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Special Signal Notification

Double Bottom Formation

Double Bottom Formation A buy signal from a double bottom formation was found on Friday, November 05, 2021 with a target of $0.000067. Despite whether the objective of the signal formation has been reached the stock may continue to perform well.

Support, Risk & Stop-loss

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had a daily average volatility of 0%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Anthera Pharmaceuticals stock A Buy?

Anthera Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -5.375

Predicted Opening Price for Anthera Pharmaceuticals of Monday, November 29, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price November 29, 2021 Current price
$0.0001 $0.0001 (Undervalued)
Strong Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Volatility and Risk
Daily Average Volatility: 0 %
Overall Risk: Very High High Medium Low Very Low
0 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

No Resistance Found
Price: $0.0001
No Support Found

ANTH Insider Trading Show all Trades



Last 100 transactions
Buy: 7 315 093 | Sell: 288 719 (Shares)
Date Action Amount Person Type
Jan 05, 2018 Buy 427 066 Liu May Stock Option (right to buy)
Jan 05, 2018 Buy 84 705 Henney Christopher S Stock Option (right to buy)
Jan 05, 2018 Buy 84 705 Mueller Brian Stock Option (right to buy)
Jan 05, 2018 Buy 567 876 Shanahan William R Jr Stock Option (right to buy)
Jan 05, 2018 Buy 1 847 074 Thompson John Craig Stock Option (right to buy)
Show all Insider Trades


Last 100 transactions
Buy: 7 315 093 | Sell: 288 719 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 0.0001 .
0.0001 .
0.0001 .
Current price: 0.0001
Support 0.0001 .
0.0001 .
0.0001 .

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 0 .
0 .
0 .
Current price 0.0001
Support 0 .
0 .
0 .

Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. The company’s Phase III product candidates include liprotamase or Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod that targets B-cell activating factor associated with vario... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE